Invesco Ltd. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$112,367,756
+17.5%
706,671
+4.5%
0.03%
+20.0%
Q2 2023$95,641,815
-59.1%
676,105
-51.4%
0.02%
-61.5%
Q1 2023$234,018,073
-12.0%
1,389,986
-11.5%
0.06%
-16.7%
Q4 2022$265,987,025
-23.2%
1,571,006
-15.1%
0.08%
-29.7%
Q3 2022$346,391,000
+13.7%
1,851,271
-1.3%
0.11%
+20.7%
Q2 2022$304,670,000
-7.8%
1,876,048
+6.8%
0.09%
+9.5%
Q1 2022$330,315,000
-26.2%
1,756,157
+3.9%
0.08%
-22.2%
Q4 2021$447,742,000
-27.5%
1,690,607
-20.9%
0.11%
-31.2%
Q3 2021$617,681,000
+32.2%
2,137,382
-8.7%
0.16%
+36.5%
Q2 2021$467,320,000
+4.8%
2,341,043
+2.1%
0.12%
-3.4%
Q1 2021$445,962,000
-6.3%
2,293,926
-7.6%
0.12%
-14.4%
Q4 2020$475,912,000
+45.8%
2,483,496
+12.3%
0.14%
+26.4%
Q3 2020$326,328,000
+33.0%
2,211,795
+11.4%
0.11%
+25.0%
Q2 2020$245,373,000
+9.5%
1,985,062
-14.5%
0.09%
-6.4%
Q1 2020$224,055,000
+3.3%
2,320,844
-1.0%
0.09%
+40.3%
Q4 2019$216,825,000
+10.9%
2,344,056
-8.0%
0.07%
+31.4%
Q3 2019$195,470,000
-26.4%
2,548,844
-17.5%
0.05%
-25.0%
Q2 2019$265,465,000
+122.5%
3,088,594
+53.0%
0.07%
+70.0%
Q1 2019$119,300,000
+6.7%
2,019,310
-4.7%
0.04%
-7.0%
Q4 2018$111,759,000
-13.0%
2,119,043
-8.5%
0.04%
+7.5%
Q3 2018$128,429,000
+34.6%
2,315,707
+14.2%
0.04%
+25.0%
Q2 2018$95,381,000
+60.5%
2,027,646
+23.5%
0.03%
+45.5%
Q1 2018$59,424,000
+4.7%
1,642,459
+5.0%
0.02%
+10.0%
Q4 2017$56,737,000
-11.8%
1,563,866
-6.9%
0.02%
-16.7%
Q3 2017$64,342,000
-7.0%
1,679,059
+0.6%
0.02%
+9.1%
Q2 2017$69,178,000
+21.9%
1,669,359
+3.5%
0.02%
+15.8%
Q1 2017$56,757,000
+10.4%
1,612,429
-3.3%
0.02%
+11.8%
Q4 2016$51,401,000
-2.6%
1,667,763
-4.6%
0.02%
-5.6%
Q3 2016$52,798,000
+6.3%
1,748,867
-3.6%
0.02%0.0%
Q2 2016$49,659,000
+2.5%
1,815,025
+0.5%
0.02%
-10.0%
Q1 2016$48,449,000
-14.1%
1,806,436
-9.4%
0.02%
-13.0%
Q4 2015$56,422,000
+3.5%
1,994,389
+1.9%
0.02%0.0%
Q3 2015$54,534,000
-30.0%
1,958,114
+3.7%
0.02%
-25.8%
Q2 2015$77,910,000
+24.6%
1,887,804
-8.3%
0.03%
+29.2%
Q1 2015$62,516,000
+82.7%
2,059,142
+19.2%
0.02%
+84.6%
Q4 2014$34,210,000
+117.5%
1,727,787
+118.7%
0.01%
+116.7%
Q3 2014$15,726,000
+81.8%
789,877
+108.2%
0.01%
+100.0%
Q2 2014$8,648,000
+126.9%
379,457
+28.0%
0.00%
+50.0%
Q1 2014$3,812,000
+31.1%
296,448
+39.0%
0.00%
+100.0%
Q4 2013$2,908,000
+332.1%
213,226
+251.2%
0.00%
Q3 2013$673,000
+3.2%
60,715
-23.3%
0.00%
Q2 2013$652,00079,1110.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders